| 2.3 |
13.7 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.6 |
4.8 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 1.4 |
7.0 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 1.3 |
5.3 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 1.2 |
4.8 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.9 |
2.8 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.9 |
4.3 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.8 |
3.4 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.8 |
4.0 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.8 |
2.3 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.8 |
1.5 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.7 |
4.3 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.6 |
1.9 |
GO:0040009 |
regulation of growth rate(GO:0040009) protein poly-ADP-ribosylation(GO:0070212) |
| 0.6 |
1.9 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.5 |
2.1 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.5 |
2.6 |
GO:0090666 |
telomere assembly(GO:0032202) scaRNA localization to Cajal body(GO:0090666) |
| 0.5 |
1.5 |
GO:0002295 |
T-helper cell lineage commitment(GO:0002295) interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.5 |
1.5 |
GO:0019405 |
hexitol metabolic process(GO:0006059) alditol catabolic process(GO:0019405) fructose biosynthetic process(GO:0046370) |
| 0.5 |
2.9 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.5 |
3.7 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.5 |
1.8 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.5 |
2.3 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.4 |
8.0 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.4 |
1.7 |
GO:0071609 |
chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.4 |
10.5 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.4 |
1.7 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.4 |
0.8 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.4 |
3.5 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.4 |
1.6 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.4 |
2.3 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.4 |
3.5 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.4 |
1.9 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.4 |
1.1 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.4 |
1.8 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.3 |
1.7 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 |
1.7 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.3 |
1.0 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.3 |
1.3 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.3 |
1.0 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.3 |
1.0 |
GO:0045014 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) detection of glucose(GO:0051594) |
| 0.3 |
2.5 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.3 |
2.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 |
1.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.3 |
0.9 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 |
0.9 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 |
0.8 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.3 |
0.8 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 |
1.7 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.3 |
0.6 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.3 |
1.4 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.3 |
0.8 |
GO:0007521 |
muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
| 0.3 |
1.3 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.3 |
1.3 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.3 |
0.8 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.3 |
1.3 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.3 |
1.3 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 |
1.6 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.3 |
2.6 |
GO:0046036 |
GTP biosynthetic process(GO:0006183) CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.3 |
3.6 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.3 |
0.5 |
GO:0061349 |
planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) |
| 0.2 |
1.7 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.2 |
0.7 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.2 |
0.2 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 |
0.2 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.2 |
2.3 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.2 |
2.8 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.2 |
0.5 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.2 |
2.2 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.2 |
1.1 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.2 |
0.9 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.2 |
0.6 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.2 |
3.1 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.2 |
0.6 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.2 |
0.2 |
GO:0043373 |
CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
| 0.2 |
1.4 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.2 |
0.6 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.2 |
0.6 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 |
0.8 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.2 |
1.0 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.2 |
0.6 |
GO:0070543 |
response to linoleic acid(GO:0070543) |
| 0.2 |
0.6 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 |
1.1 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 |
0.9 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.2 |
2.7 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.2 |
1.1 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.2 |
1.3 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.2 |
1.8 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.2 |
0.2 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.2 |
1.8 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 |
1.7 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.2 |
1.4 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 |
7.5 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.2 |
1.0 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.2 |
1.0 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
1.0 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.2 |
0.5 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.2 |
1.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
0.9 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.2 |
2.7 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
1.0 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
0.4 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.1 |
2.6 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.4 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
0.6 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 |
0.3 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
0.7 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.1 |
1.1 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.1 |
1.0 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
1.0 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.4 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
1.6 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
0.5 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
1.2 |
GO:0002155 |
regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 |
2.0 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.5 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.1 |
0.1 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
1.3 |
GO:0048853 |
forebrain dorsal/ventral pattern formation(GO:0021798) forebrain morphogenesis(GO:0048853) |
| 0.1 |
2.3 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
2.1 |
GO:0017144 |
drug metabolic process(GO:0017144) |
| 0.1 |
0.6 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.4 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.2 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.6 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.1 |
0.7 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.7 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
2.7 |
GO:0010883 |
regulation of lipid storage(GO:0010883) |
| 0.1 |
0.4 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
1.9 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.5 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
1.5 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.1 |
0.9 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
1.7 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 |
0.4 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.8 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
2.2 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.8 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.1 |
1.7 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 |
0.6 |
GO:1901978 |
positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.1 |
1.5 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
1.3 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
2.3 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
1.4 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.1 |
0.2 |
GO:1904749 |
protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 |
3.7 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 |
0.3 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.1 |
0.3 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.4 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
1.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.2 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.1 |
0.3 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
1.0 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
2.4 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
1.0 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
1.9 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.8 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 |
1.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.8 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.1 |
0.4 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.3 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 |
1.8 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 |
0.9 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
1.3 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.7 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) DNA strand elongation(GO:0022616) mitotic DNA replication(GO:1902969) |
| 0.1 |
0.9 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.1 |
1.3 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.3 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.1 |
0.7 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
0.2 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 |
0.3 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.2 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.1 |
0.5 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 |
1.3 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.3 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.1 |
1.1 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.1 |
1.4 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
1.0 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.1 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.1 |
0.2 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 |
0.3 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
1.0 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.4 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.3 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 |
0.4 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 |
2.0 |
GO:0042632 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.1 |
0.2 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
1.5 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
2.1 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.2 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.0 |
0.2 |
GO:0090220 |
telomere localization(GO:0034397) meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.0 |
0.2 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.0 |
0.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.0 |
0.8 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
1.0 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
1.9 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.0 |
0.2 |
GO:0032956 |
regulation of actin cytoskeleton organization(GO:0032956) |
| 0.0 |
0.6 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
3.3 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.0 |
0.9 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.5 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.2 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.0 |
0.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.5 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.1 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.0 |
0.6 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.7 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.6 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 |
0.8 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.9 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.0 |
0.2 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 |
0.3 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.0 |
1.7 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 |
1.0 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
2.8 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.0 |
0.4 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
1.0 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.0 |
0.2 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.0 |
1.1 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 0.0 |
0.3 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.1 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.0 |
0.5 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
1.1 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.0 |
0.2 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.0 |
1.5 |
GO:0031960 |
response to corticosteroid(GO:0031960) response to glucocorticoid(GO:0051384) |
| 0.0 |
0.4 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.6 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.4 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.0 |
1.4 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
0.7 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.8 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
0.3 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.9 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.0 |
1.2 |
GO:0046785 |
microtubule polymerization(GO:0046785) |
| 0.0 |
0.4 |
GO:0006978 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.0 |
2.1 |
GO:0008584 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.0 |
0.3 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
1.2 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.4 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.8 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.5 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.2 |
GO:1901992 |
positive regulation of mitotic cell cycle phase transition(GO:1901992) |
| 0.0 |
0.5 |
GO:1901031 |
regulation of response to reactive oxygen species(GO:1901031) |
| 0.0 |
2.8 |
GO:0000082 |
G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.0 |
0.7 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.2 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.2 |
GO:0032753 |
positive regulation of interleukin-4 production(GO:0032753) |
| 0.0 |
0.9 |
GO:0071594 |
T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.0 |
0.9 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.0 |
5.9 |
GO:0007067 |
mitotic nuclear division(GO:0007067) |
| 0.0 |
0.8 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
| 0.0 |
0.1 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.0 |
1.5 |
GO:0030177 |
positive regulation of Wnt signaling pathway(GO:0030177) |
| 0.0 |
0.5 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 |
1.3 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.4 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
0.2 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 0.0 |
0.1 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.4 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.0 |
0.1 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.0 |
0.2 |
GO:0010799 |
regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.1 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 |
0.4 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.0 |
0.1 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 |
0.3 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.6 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.0 |
0.2 |
GO:0009651 |
response to salt stress(GO:0009651) |
| 0.0 |
0.4 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
1.1 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 |
0.2 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.6 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.3 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.3 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 |
1.6 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.0 |
0.5 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.0 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.0 |
0.1 |
GO:1901799 |
negative regulation of proteasomal protein catabolic process(GO:1901799) |
| 0.0 |
0.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.0 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
